The Emicizumab assay is now performed in special coagulation at QEHB. Samples are no longer referred to Birmingham Children's Hospital.
Emicizumab (or Hemlibra) is a monoclonal antibody that mimics the function of factor VIII by bridging activated factor IX and factor X to restore the function of missing activated factor VIII, which is needed for haemostasis.
created on Friday, 01 September 2023.
Posted in Haematology
on Friday, 01 September 2023
Due to supply issues there has been a change to the manufacturer of our malaria antigen kits effective from 26/08/2022 . The new test kit has been verified and is awaiting ISO accreditation at our next UKAS visit.
created on Wednesday, 23 November 2022.
Posted in Haematology
on Wednesday, 23 November 2022